Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 75–75 | Cite as

Blinatumomab/dasatinib/ponatinib

Various toxicities: 9 case reports
Case report

Reference

  1. Assi R, et al. Safety and efficacy of blinatumomab in combination with A tyrosine kinase inhibitor for the treatment of relapsed philadelphia chromosome-positive leukemia. Blood 130 (Suppl. 1): 2598, Dec 2017 [abstract] - USAGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations